PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

Recruiting Phase 3 Interventional Study
All-cause Mortality Quality of Life Disability, Intellectual Neurological Disorder Acute Brain Injury Ventilation, Mechanical Intensive Care Medicine
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
3,300 (estimated)
Sponsor
The George Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This research is about whether treatment with a commonly used antibiotic can prevent infections in airway and lungs and improves the chance of surviving, if it is given soon after patients commence mechanical ventilation when they have been admitted to hospital with an acute severe brain injury. An acute severe brain injury can occur as a result of a stroke, a traumatic injury or due to lack of o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years of age 2. Receiving invasive mechanical ventilation 3. The requirement for mechanical ventilation is because of an acute brain injury due to intracranial haemorrhage, ischaemic stroke, cerebral venous sinus thrombosis, subarachnoid haemorrhage, suspected hypoxic is…
Contacts

Tina Schneider

+61 02 8052 4562

tschneider@georgeinstitute.org.au

CONTACT

Dorrilyn Rajbhandari

+61 02 8052 4301

drajbhandari@georgeinstitute.org.au

CONTACT